PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product ...

0 PMV Electric says that their first car will get a digital infotainment system and a USB charging port(PMV) PMV, a Mumbai based electric vehicle manufacturer, is all set to launch its micro-electric ...